Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area Sort descending
  • Date Posted
Job Title Site Location Division Business Functional Area Sort descending Date Posted
Senior Global Labelling Coordinator London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 25, 2024
Global Labelling Manager Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Oct 25, 2024
GCP Bioanalysis Sr Principal Scientist Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 25, 2024
RA Head India Mumbai (Head Office) India Development Sandoz Research & Development Oct 25, 2024
Medical Science Liaison - Rheumatology - Ontario Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 25, 2024
Analytical Expert – Trace Level Analytics (m/f/d) Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 25, 2024
Expert Science & Technology – Trace level analytics (e.g. nitrosamines, genotoxic impurities) Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 25, 2024
Director, Statistical Programming East Hanover (New Jersey) USA Development Innovative Medicines Research & Development Oct 25, 2024
Senior Clinical Sciences Trial Leader (Multiple Positions) East Hanover (New Jersey) USA Biomedical Research Pharma Research Research & Development Oct 25, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Country/ Cluster Head CRMA Ramallo (Argentina) Argentina Development Innovative Medicines Research & Development Aug 15, 2024
RA Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Sep 03, 2024
Clinical Research Medical Advisor Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Sep 06, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Coordinator, Global Program Management and Portfolio Excellence INSURGENTES Mexico Biomedical Research CTS Research & Development Oct 15, 2024
Feasibility Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Oct 16, 2024
Oncology MSL INSURGENTES Mexico International Innovative Medicines Research & Development Oct 18, 2024
Patient Journey Partner Lead GTx INSURGENTES Mexico International Innovative Medicines Research & Development Oct 21, 2024
Chef, Éducation médicale - Cancer du sein Montreal Canada International Innovative Medicines Research & Development Oct 18, 2024
Liaison en sciences médicales - Cancer du sein Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 23, 2024
Liaison en sciences médicales - Rheumatologie - Ontario Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 25, 2024
MSL Tumeurs Solides - Nord Est Field Non-Sales (France) France International Innovative Medicines Research & Development Apr 29, 2024
Medical Head Radioligand Therapy Rueil-Malmaison France International Innovative Medicines Research & Development Jun 02, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Patient Safety Manager Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Sep 04, 2024
RWE Lead H/F CDD 12 mois Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Research & Development Oct 04, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Head, Clinical Development Business Solutions Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 10, 2024
Central Integrated Scientific Review Committee Lead Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Oct 14, 2024
Associate Director, Clinical Processes & Solutions Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Oct 14, 2024
Head Clinical Development Business Solutions East Hanover USA Development Innovative Medicines Research & Development Oct 18, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Oct 09, 2024
Medical Head Oncology Milano Italy International Innovative Medicines Research & Development Oct 14, 2024
Clinical Research Associate Field Force (Italy) Italy Development Innovative Medicines Research & Development Oct 16, 2024
Senior Lead, TA Medical(General Medicines) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development May 27, 2024
Clinical Biospecimen Senior Scientist Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 03, 2024
Lead, Medical Excellence Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Jul 02, 2024
TME Profiling Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 07, 2024
Clinical Sciences Trial Leader Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 10, 2024
Lead, RWE and Evidence Excellence Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Jul 10, 2024
Senior Specialist - Automation Engineer Sasayama Japan Operations Research & Development Jul 16, 2024
Senior Statistical Programmer Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 18, 2024
Associate/Manager, MSL(Oncology) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Jul 22, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate/Manager, MSL (Cardiovascular) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Aug 20, 2024
Medical Field Trainer Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Aug 29, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 05, 2024
Group Manager, MSL Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Sep 05, 2024
Japan Program Clinical Head (IMM) Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Innovative Medicines Research & Development Sep 10, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 42
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia